IN2014MU00665A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MU00665A IN2014MU00665A IN665MU2014A IN2014MU00665A IN 2014MU00665 A IN2014MU00665 A IN 2014MU00665A IN 665MU2014 A IN665MU2014 A IN 665MU2014A IN 2014MU00665 A IN2014MU00665 A IN 2014MU00665A
- Authority
- IN
- India
- Prior art keywords
- binder
- disintegrant
- ratio
- containing compound
- calcium containing
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The present disclosure relates to an oro-dispersible tablet comprising: at least one calcium containing compound; at least one binder; at least one disintegrant; and at least one pharmaceutically acceptable excipient. The tablet is characterized in that, the ratio of the binder to the calcium containing compound ranges between 1:20 and 1:25; the ratio of the disintegrant to the calcium containing compound ranges between 1:2 and 1:4; and the ratio of the binder to the disintegrant ranges between 1:6 and 1:11. The present disclosure relates to a process for preparing the oro-dispersible tablet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN665MU2014 IN2014MU00665A (en) | 2014-02-25 | 2014-02-25 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN665MU2014 IN2014MU00665A (en) | 2014-02-25 | 2014-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MU00665A true IN2014MU00665A (en) | 2015-10-23 |
Family
ID=54394113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN665MU2014 IN2014MU00665A (en) | 2014-02-25 | 2014-02-25 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2014MU00665A (en) |
-
2014
- 2014-02-25 IN IN665MU2014 patent/IN2014MU00665A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017004876A (en) | Process for preparing a directly compressible erythritol & uses thereof. | |
PH12017501035A1 (en) | Method for the production of a pharmaceutical delivery system | |
PH12018501237A1 (en) | Isoindole compounds | |
PH12016501841A1 (en) | Immunosuppressant formulation | |
MX2020002123A (en) | Ribociclib salts and solid state forms thereof. | |
MX2017001487A (en) | Sofosbuvir in crystalline form and process for its preparation. | |
IN2014MU00455A (en) | ||
IN2013MU00646A (en) | ||
IN2014DN06966A (en) | ||
MX2020009444A (en) | Low dose oral pharmaceutical composition of isotretinoin. | |
MX2017015137A (en) | Once daily oral pharmaceutical composition of isotretinoin. | |
MX2016015464A (en) | Oral pharmaceutical composition of isotretinoin. | |
IN2013MU03862A (en) | ||
IN2013MU01985A (en) | ||
IN2014MU00916A (en) | ||
MX2017015322A (en) | Oral pharmaceutical composition of isotretinoin. | |
EA202090913A1 (en) | COMPOSITION OF MODIFIED RELEASE TABLETS CONTAINING MIRABEGRON | |
IN2013MU01111A (en) | ||
WO2015087343A3 (en) | An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof | |
IN2014MU00495A (en) | ||
MX2015011881A (en) | Process for the preparation of 3,7-dimethylnonan-1-ol. | |
IN2014MU00215A (en) | ||
IN2014MU00665A (en) | ||
IN2013CH04314A (en) | ||
MX2017007510A (en) | A process for the manufacture of idalopirdine. |